Volume 1 Issue 3 – Winter 2005
Uprooting the Stem Cell Controversy-Why Human Embryonic Stem Cell Research is Wrong – A NextGen Undergraduate Journal Club Discussion
A submission from an undergraduate journal club on Embryo Ethics: The Moral Logic of Stem-Cell Research, by M.J. Sandel, NEJM, July 15 2004, Vol 351(3)
Merck’s Recall of Rofecoxib-A Strategic Perspective – An NEJM Original Article
Perspective Article by F. Oberholzer-Gee and S.N. Inamdar, NEJM, November 18 2004, Vol 351(21)
Merck’s withdrawal of the painkiller Vioxx and the resulting $28 billion drop in the company’s market value discourages the confidence of patients and physicians in the pharmaceutical industry. Oberholzer-Gee and Inamdar address Merck’s balance between patient safety and profit and its unique business strategy within the industry.
Rationing Influenza Vaccine – An NEJM Original Article
Perspective Article by T.H. Lee, NEJM, December 2 2004, Vol 351(23)
Reflecting on his personal experiences with the current flu vaccine shortage, Dr. Thomas Lee remarks on the future of rationing in American health care.
The Limits of Conscientious Objection – May Pharmacists Refuse to Fill Prescriptions for Emergency Contraception? – An NEJM Original Article
Sounding Board by J. Cantor and K. Baum, NEJM, November 4 2004, Vol 351(19)
The FDA’s decision not to give the emergency contraceptive Plan B over-the-counter status has amplified the conflict between a patient’s needs and a pharmacist’s refusal to fill prescriptions. The debate over the “morning after pill” is one part of a larger debate on the role of personal ethics in medical care delivery.
NextGen Talks to the Primary Author: M.B. Landon
Dr. Mark B. Landon talks to the Next Generation about his study on the risks associated with trial of labor after a prior cesarean delivery (“Maternal and Perinatal Outcomes Associated with a Trial of Labor after Prior Cesarean Delivery”).
Maternal and Perinatal Outcomes Associated with a Trial of Labor after Prior Cesarean Delivery – An NEJM Original Article
Original Article by M.B. Landon et al., NEJM, December 16 2004, Vol 351(25)
Many clinicians have discouraged pregnant women from choosing a vaginal delivery after a previous cesarean delivery. Do the risks to the mother and newborn justify a surgical procedure over a natural trial of labor?
Money in Medicine: The National Institutes of Health
The Second Installment of NextGen’s “Money in Medicine” Series
The Next Generation interviewed Brent Stanfield, Acting Director of the Center for Scientific Review, and Anthony Demsey, Senior Policy Advisor for the Office of Extramural Research, at NIH to give our readers a glimpse into the innerworkings of NIH, the largest public funding source for health sciences research in the U.S.
A Day in the Life of Terri Halperin, Surgery Resident
The Second Installment of NextGen’s “A Day in the Life of a Physician” Series
For the second installment of our “A Day in the Life of a Physician” series, we interviewed a reconstructive/plastic surgery resident in the Harvard Plastic Surgery Program in Boston, MA. In this Special Feature, Dr. Halperin discusses her views on residency, her choice of surgery as a discipline, and balancing the challenges of residency and being an expecting mother.
